FoxBio Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
FoxBio General Information
Description
Developer of a small molecule therapy designed to reduce senescent cells in human bodies. The company's therapy targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age-related diseases.
Contact Information
Corporate Office
- 2561 US Route 11
- LaFayette, NY 13084
- United States
Corporate Office
- 2561 US Route 11
- LaFayette, NY 13084
- United States
FoxBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 03-Jun-2024 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 12-Jul-2018 | Completed | Startup | |||
| 1. Joint Venture | 12-Jul-2018 | $10M | Completed | Startup |
FoxBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
FoxBio FAQs
-
When was FoxBio founded?
FoxBio was founded in 2018.
-
Where is FoxBio headquartered?
FoxBio is headquartered in LaFayette, NY.
-
What industry is FoxBio in?
FoxBio’s primary industry is Drug Discovery.
-
Is FoxBio a private or public company?
FoxBio is a Private company.
-
What is FoxBio’s current revenue?
The current revenue for FoxBio is .
-
How much funding has FoxBio raised over time?
FoxBio has raised $1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process